Clinical Trial Update: Evaluation of RC28-E Injection in Diabetic Macular Edema [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating RC28-E injection for diabetic macular edema has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• RC28-E

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED